Oyster Therapeutics Secures $60 Million via Series A Extension
LLY Lilly(Eli) & Co
$1437.29 +0.35%
View chart & analysis → - 1Oyster Therapeutics has secured $60 million through a Series A extension funding round.
- 24BIO Capital led the Series A-2 round with Eli Lilly participating in the investment group.
- 3Oyster Therapeutics will begin a research collaboration with Massachusetts General Hospital.
So what's the key point?
Oyster Therapeutics received an additional $60 million in funding. With participation from 4BIO Capital and Eli Lilly, the company has gained resources to conduct research.
Source BioPharma Dive · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.